Colin Dollery: clinical pharmacologist and moderniser, who embraced technology

BMJ ◽  
2021 ◽  
pp. n582
Author(s):  
Chris Mahony
Keyword(s):  
Clinical Pharmacologist

Polypharmacy and the Older Patient: The Clinical Pharmacologist Perspective

2020 ◽  
pp. 91-104
Author(s):  
Paula Scibona ◽  
Maria Valeria Beruto ◽  
Nadia E. Savoy ◽  
Ventura A. Simonovich
Keyword(s):  
Clinical Pharmacologist ◽  
Older Patient

scholarly journals From the Origins of Pharmacogenetics to First Applications in Psychiatry

2019 ◽  
Vol 53 (04) ◽  
pp. 155-161 ◽  
Author(s):  
Daniel J. Müller ◽  
Zoe Rizhanovsky
Keyword(s):  
Side Effects ◽  
Clinical Outcome ◽  
Conceptual Framework ◽  
Drug Targets ◽  
Genetic Factors ◽  
Psychiatric Treatment ◽  
Clinical Pharmacologist ◽  
Genetic Traits ◽  
Future Studies ◽  
Practical Implications

AbstractPharmacogenetics is the division of science addressing how genetic factors contribute to the metabolism, response, and side effects of a given medication. What was once regarded as a subdivision of genetics and pharmacology is now recognized as its own field and has its own unique story of origin. While the term “pharmacogenetics” was coined by Friedrich Vogel in 1959, the relevance of inherited genetic traits in affecting the clinical outcome to xenobiotics has been observed long before. In fact, there is much hope that pharmacogenetics can help unravel the “mysteries” as to why different people may display variable responses to the same medication as well as identify new drug targets. This article will highlight the conceptual framework for pharmacogenetics advanced by pioneer scientists Arno Motulsky and Friedrich Vogel (both human geneticists), as well as Werner Kalow (clinical pharmacologist), leading up to the creation of modern pharmacogenetics. Finally, the practical implications and first steps toward implementation for current psychiatric treatment are reviewed followed by an outlook on future studies.

Sign in / Sign up

Export Citation Format

Share Document